---
title: "AVITA Medical Q4 Earnings Summary & Key Takeaways"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/275807142.md"
description: "AVITA Medical (NASDAQ:RCEL) reported its Q4 earnings on February 12, 2026, beating estimates by 19.15% with an EPS of $-0.38 compared to the expected $-0.47. However, revenue decreased by $790,000 from the previous year. In the prior quarter, the company missed EPS estimates by $0.02, resulting in a 10.88% share price increase the following day. Historical performance shows fluctuations in EPS and revenue across previous quarters."
datetime: "2026-02-12T21:06:17.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/275807142.md)
  - [en](https://longbridge.com/en/news/275807142.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/275807142.md)
---

# AVITA Medical Q4 Earnings Summary & Key Takeaways

**AVITA Medical** (NASDAQ:RCEL) released its Q4 earnings on Thursday, February 12, 2026 at 04:01 PM.

Here's what's important from the earnings announcement.

### Earnings

AVITA Medical beat estimated earnings by 19.15%, reporting an EPS of $-0.38 versus an estimate of $-0.47.

Revenue was down $790 thousand from the same period last year.

### Analysis of Past Earnings

Last quarter the company missed on EPS by $0.02 which was followed by a 10.88% increase in the share price the next day.

Here's a look at AVITA Medical's past performance:

**Quarter**

**Q3 2025**

**Q2 2025**

**Q1 2025**

**Q4 2024**

**EPS Estimate**

\-0.44

\-0.32

\-0.51

\-0.74

**EPS Actual**

\-0.46

\-0.38

\-0.53

\-0.44

**Revenue Estimate**

27.70M

34.27M

32.79M

31.59M

**Revenue Actual**

16.90M

18.42M

18.51M

18.41M

To track all earnings releases for AVITA Medical visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [RCEL.US](https://longbridge.com/en/quote/RCEL.US.md)

## Related News & Research

- [AVITA Medical wins BARDA contract worth up to $25.5M](https://longbridge.com/en/news/282224300.md)
- [AVITA Medical Showcases Acute Burn and Wound Care Portfolio at ABA 2026, Featuring New Cohealyx Data | RCEL Stock News](https://longbridge.com/en/news/281926583.md)
- [Data at 2026 Boswick Burn & Wound Symposium highlight first integrated use of AVITA Medical technologies | RCEL Stock News](https://longbridge.com/en/news/273620840.md)
- [Avita Medical Targets “Progressive” 2026 Growth, Guides $80M-$85M Revenue After Headwind Year](https://longbridge.com/en/news/276815326.md)
- [D. Boral Capital Issues Pessimistic Forecast for Avita Medical (NASDAQ:RCEL) Stock Price](https://longbridge.com/en/news/272745133.md)